GTLA Signs Memorandum of Understanding to Acquire Compassionate Therapeutic Solutions, LLC; New President Appointed
Click Here to Read the Featured Report about this Company

FULLERTON, Calif., March 8, 2010 (GLOBE NEWSWIRE) -- GT Legend Automotive Holdings, Inc. (Pink Sheets:GTLA) issued a statement today that a Memorandum of Understanding has been signed for the company to acquire Compassionate Therapeutic Solutions, LLC based in Colorado Springs. Eugene Espinosa, President of Compassionate Therapeutic Solutions, will assume the role of President of GTLA.

Compassionate Therapeutic Solutions, LLC is a multidisciplinary behavioral health care practice that offers mental health, substance abuse and primary caregiver services to communities of Colorado. The company's focus is to provide cost-effective quality treatment and to create, promote, and maintain a positive customer relationship with clients, associates and the community. One of the functions of the clinic would be to provide comprehensive care to individuals who are registered and authorized to utilize medical marijuana.

Eugene Espinosa, President of CTS, has completed the course work and clinical supervision requirements for a Ph.D. from the University of Northern Colorado . His B.A. is from the University of Colorado and his M.A. was re-earned from the University of Northern Colorado . Mr. Espinosa has over thirty years experience working in government agencies. He served as Clinic Director for three Community Mental Health Centers in Nevada and as Clinical Director for the Cheyenne Mountain Re-Entry Center in Colorado. He has also been employed as a Psychologist II for the Nevada Department of Corrections . In 2004, he retired from the State of Colorado as a primary Therapist responsible for the Reintegration Opportunity Unit for the Colorado Department of Corrections . He also worked for Colorado State Hospital and Colorado State University . From 2006 to present, he has provided therapy and consulted for CTS, LLC .

Eugene Espinosa commented, "I am honored to accept my appointment as President of GTLA, and am looking forward to bringing CTS to the next level.

"In light of the recent shooting at the Pentagon, I feel obligated to address the incongruous link that some media outlets suggest between the shooter's violent choice of behavior and his reported use of marijuana. The Los Angeles Times stated in an article that the shooter, John Bedell, tended to self-medicate with marijuana (Source: http://www.latimes.com/news/local/la-me-pentagon-shooter6-2010mar06,0,4506100.story?track=rss ). Studies show that marijuana allows for improved functionality and pain relief, making it a valuable resource for qualified, registered and medically supervised users. Medical marijuana, as with any drug or controlled substance, is intended to be used under the close supervision of licensed professionals, such as those who staff CTS. CTS has been developed to identify the best therapeutic practices for medical marijuana users. In fact, we have been encouraging senators and other public officials to enforce a treatment plan to monitor medical marijuana use. Had the shooter properly utilized medical marijuana under the care and supervision of a therapist, his mental illness and behavioral tendencies would have been spotted and addressed, and this tragic incident may have been avoided. Marijuana cannot be blamed for this incident; rather, it should be attributed to a biochemical irregularity, coupled with poor choices and lack of proper supervision."

About GT Legend Automotive Holdings Inc.

GT Legend Automotive Holdings, Inc. is a Nevada research and development corporation.

Disclosure

OTCReporter.com and HotOTCChina.com are owned by Oceanic Consulting, LLC ("Oceanic") and Garden State Resources NJ, LLC ("Garden State"), both of which are New Jersey limited liability corporations (OTCReporter.com and Hot OTCChina.com and its owners, Oceanic and Garden State, and their affiliates, directors and officers and immediate family members are referred to in our Disclaimer as "OTCR" or "we" or "us" or "our). Oceanic and Garden State are referred to herein collectively as the "LLC Companies" when the context of the statements pertain to compensation matters, including our "Compensation Disclosure" section that seeks to comply with Section 17(b) of the1933 act, as amended, which states that any person who disseminates publications or other communications (through interstate commerce) for consideration received or to be received, directly or indirectly, from an issuer, underwriter, or dealer, must disclose the receipt and amount, whether past or prospective, of such consideration. The LLC Companies received two hundred eighty million of free trading shares from a non-affiliate third party shareholder of GTLA in return for OTCR’s services to publicly and electronically disseminate information pertaining to GTLA, of which two hundred eighty million free trading shares have been sold. It is imperative that all readers of the above Compensation Disclosure Section click on the link below to carefully review our Disclaimer in its entirety, which contains important information about penny stocks, our operations, the limited nature of the information presented in our publications and various risks attendant to the companies that we profile.

Click to read our disclaimer

Home   -   About Us   -   New Stock Alerts   -   Featured Reports   -   Disclaimer   -   Contact Us
© 2004-2006 OTCReporter.com, All rights reserved.